Brainstorm Cell Therapeutics Inc. (BCLI)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Diagnostic Substances

Drugs

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

21

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
13-Mar-24 8:55 PM View:	11-Mar-24 Grant 0	Patlis Alla See Remarks		Brainstorm Cell Therapeutics Inc. - BCLI	100% 0 to 65.25K	0	0	--	--	Show Txns Hide Txns

13-Mar-24 8:57 PM View:	11-Mar-24 Grant 0	Lindborg Stacy Co-Chief Executive Officer		Brainstorm Cell Therapeutics Inc. - BCLI	133% 181.5K to 423.44K	0	0	--	--	Show Txns Hide Txns

02-Oct-24 8:00 AM View:	01-Oct-24 Purchase $6.29K	Lebovits Chaim President & CEO		Brainstorm Cell Therapeutics Inc. - BCLI	(91%) 2.29M to 214.35K	0	0	--	--	Show Txns Hide Txns

13-Mar-24 8:56 PM View:	11-Mar-24 Grant 0	Yablonka Uri EVP & Chief Business Officer Director		Brainstorm Cell Therapeutics Inc. - BCLI	624% 17.54K to 126.97K	0	0	--	--	Show Txns Hide Txns

24-Jul-24 4:05 PM View:	19-Jul-24 Sale ($22.07K)	Dagher Ibrahim B. Chief Medical Officer		Brainstorm Cell Therapeutics Inc. - BCLI	(25%) 253.0K to 190.0K	0	0	--	--	Show Txns Hide Txns

25-Jun-24 9:04 PM View:	24-Jun-24 Grant 0	Hartounian Hartoun EVP, Chief Operating Officer		Brainstorm Cell Therapeutics Inc. - BCLI	100% 0 to 30.0K	0	0	--	--	Show Txns Hide Txns